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Objective / To explore patient factors related to the use of prescribed
and non-prescribed drugs for dyspepsia in The Netherlands.
Design / Patient survey study.
Setting and subjects / Questionnaires sent to patients who had a
prescription for dyspepsia medication from their general practitioner.
Main outcome measures / Patient factors related to the on-demand
use of prescribed medication and the use of non-prescribed medication
for dyspepsia.
Results / 74% of the (n/518) patients had been receiving prescribed
medication for dyspepsia for more than one year. A quarter of the
patients were using the prescribed medication ‘‘on demand’’ instead of
adhering to the instructions on the prescription. PPI prescriptions
reduced the probability of using the medication on demand, compared
with other prescribed drugs (OR 0.39). Some 19% of the patients were
using non-prescribed drugs for dyspepsia. More of the patients who
had visited their general practitioner in the previous 12 months were
using their drugs on demand (OR 2.27) and were using non-prescribed
drugs (OR 2.40) than the patients who had not visited their GP.
Conclusion / Clear information for patients on how to use their
medication for dyspepsia may contribute to decreasing unnecessary
drug use. Communication about (in)appropriate use of drugs ‘‘on
demand’’, non-prescribed drugs, and health education should be
addressed to all patient groups. Further studies on these topics should
aim to improve medical care based on shared decision-making for
patients with dyspepsia.
Key words: medication use, dyspepsia, general practice, patient survey
study.
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Most patients who seek advice for dyspeptic symp-
toms from a GP receive a drug prescription (1,2),
usually for acid-suppressive drugs. Over the past 10
years, the cost of acid-suppressive medication has
increased by 60%, mainly due to an increase in PPI
(proton pump inhibitor) prescriptions (3/5). Compli-
ance with treatment is crucial for achieving clinical
benefit but patients with dyspepsia do not always use
the medication according to instructions (6,7). It is
important to understand patterns of dyspepsia med-
ication use, because these are likely to influence
clinical effectiveness as well as cost on a societal level.
This study explored factors underlying the use of
dyspepsia medication in patients who had recently
received a prescription.
Inadequate use of prescribed drugs and the use of
non-prescribed drugs for dyspepsia are two different
aspects of medication behaviour by patients. Using
drugs ‘‘on demand’’ refers to a patient’s decision to
take the drugs according to the perceived need and is
an expression of non-adherence to treatment.
Although the use of acid-suppressive drugs ‘‘on
demand’’ has been recommended (8,9), previous and
recent Dutch clinical guidelines for general practice do
not recommend this because of incomplete evidence
(10,11). The clinical impact of non-prescribed drug use
for dyspepsia is unclear (12,13) but is a potential
competitor for prescribed medication. Severity of
symptoms is probably related to use ‘‘on demand’’
(8) or to the use of non-prescribed drugs. In most
consultations, the use of prescribed medication is not
discussed explicitly (14) and GPs rarely discuss
patients’ use of non-prescribed medication (15,16).
Greater insight is needed into associations between
patient medication behaviour and characteristics of
consultations and patient characteristics.
An observational study was performed to gain
insight into patient factors associated with the on-
Patients with dyspepsia do not always use their
medication according to instructions. It is im-
portant to understand patterns of medication
use, because of clinical effectiveness as well as
cost.
. A quarter of all patients used their prescribed
medication on demand; when using PPIs the
probability of on-demand use decreased.
. Consultation with the GP in the past 12
months was associated with on-demand use
and with use of over-the-counter medication.
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demand use of prescribed medication and the use of
non-prescribed medication.
MATERIAL AND METHODS
An observational study was performed, based on
questionnaire surveys among patients. The local
research ethics committee approved the research
protocol.
Subjects
Ten general practitioners (GPs) from two districts in
The Netherlands selected all patients who had received
a prescription for one of five categories of dyspepsia
drugs (antacids, prokinetics, mucosa-protectives, h2
receptor antagonists (h2RAs), and proton pump
inhibitors (PPIs) recommended by the Dutch Formu-
lary (17). Exclusion criteria were age under 18 years,
not being able to fill in the questionnaire, and serious
disease. GPs used an electronic medical record system
to select recent prescriptions by using A(natomical)
T(herapeutic) C(lassification) codes, or they identified
medication from the complete electronic list of drugs
that belong to the five categories according to the
Formulary. A total of 803 patients were selected and
approached.
Variables
A written questionnaire was developed to measure the
following dependent variables: (a) the use of pre-
scribed medication, measured by questions on the
frequency of use of this medication (6 answer cate-
gories: daily, never, and four modifications of ‘‘some-
times’’). Use ‘‘on demand’’ was defined as using the
prescribed drug according to one of the four mod-
ifications of ‘‘sometimes’’ for example ‘‘some weeks on
and off’’ or ‘‘several times a week’’; (b) the use of non-
prescribed drugs for dyspepsia, measured by questions
on non-prescribed medication for dyspepsia purchased
in the previous four weeks. The following options were
suggested: h2RAs, antacids, and other non-prescribed
medication for dyspepsia.
Independent variables included: (a) patient’s age,
sex, and education level (7 categories), measured with
single questions; (b) date of first GP visit for dyspepsia
symptoms (6 weeks ago, 3 or 6 months ago, or more
than a year ago); (c) number of GP visits in the
previous 12 months (from zero to 6, or more than 6
times using 8 categories); (d) prescribed medication
(patients were asked to look at their prescriptions
when filling in the questionnaire and tick the relevant
medication on a list of all available drugs according to
the formulary for dyspepsia); (e) duration of drug use
(period of 6 weeks, 3 to 6 months, or a year or more);
(f) continuous use of the drug: ‘‘did you use these
drugs all the time since the first prescription without
long periods of no usage’’ (yes or no); (g) co-
medication use e.g. analgesics, sedatives or hypnotics
(a list of the most commonly prescribed drugs which
could be ticked); (h) perceived causes for changes in
complaints (medication use, diet, personal circum-
stances, and changes in alcohol or tobacco use, or no
idea); two validated instruments were used to measure
patients’ health status; (i) dyspepsia severity (standard
instrument) (18); (j) mental health and vitality (stan-
dard instrument) (19).
Procedure
Questionnaires were sent to the patients at home.
Patients were asked to fill in and return the ques-
tionnaire after giving informed consent. Reminders
were sent to non-responders after 3 weeks. For a non-
response analysis, information (age, sex, and duration
of medication use) was collected from the electronic
medical record systems on a sample of non-responders
(12%).
Analyses
Bivariate analyses, multivariate analyses, and logistic
regression with significant variables were used to
determine associations. The two dependent variables
in the logistic regression analyses were use ‘‘on
demand’’ of prescribed medication and use of non-
prescribed medication for dyspepsia. Associations
with all independent variables were examined, except
for possible causes for change in which only the
category ‘‘medication as a cause’’ was included in
the analyses. For multivariate analyses, all related
independent variables were included in logistic regres-
sion analyses.
RESULTS
A total of 518 patients completed the questionnaire
(64.5%). Table I shows that the mean age was 58.6
years and that 61% were 55 years or older. Slightly
more than half of the sample (56%) were women. The
majority of patients (78%) had first visited their GP
for dyspepsia more than a year ago. In the previous 12
months, 22% had visited their GP more than twice.
Symptoms of upper abdominal pain, abdominal dis-
comfort, heartburn, or acid regurgitation were present
in 93% of the patients. About half (47%) of the
patients reported severe symptoms.
There were no significant differences in age or sex
between non-responders and responders (non-respon-
ders mean age 57.42, 53% women), but fewer non-
responders had received drug prescriptions for more
than one year (OR 1.234).
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Use of prescribed medication
More than half of the patients had prescriptions for
PPIs (60%). The majority (74%) had been using the
medication for more than one year; 64% reported
daily use of the prescribed medication. A quarter
(25%) of the patients were using the medication ‘‘on
demand’’ (Table II). More of the patients who had
visited their GP once or twice in the past 12 months
were using their drugs on demand (33%) than patients
who had not visited their GP (OR 2.27 (Table III)).
Furthermore, the probability of using PPIs on demand
was smaller than that of other prescribed drugs (OR
0.39).
Non-prescribed drugs for dyspepsia were being used
by 19% of the patients (Table III). Patients who
reported more severe dyspepsia symptoms were using
fewer non-prescribed drugs (OR 0.39). More of the
patients who had visited their GP 3 to 6 times in the
previous 12 months were using non-prescribed drugs
than patients who had not visited their GP at all in the
previous 12 months (OR 2.40). Lower education level
was associated with more usage of non-prescribed
drugs than higher education levels (22% versus 15%),
but the difference was not significant.
A total of 61% of the patients were using their
prescribed medication continuously. This continuous
use of prescribed medication meant that there was a
lower probability of non-prescribed drug use (OR
0.06). Patients with a higher score on the mental
health scale (i.e. feeling better) reported less use of
non-prescribed drugs (OR 0.56).
DISCUSSION
This study on patients who had been prescribed
dyspepsia medication by their GP showed that a
quarter of them were using the drugs on demand,
although the national clinical guidelines advise con-
tinuous use of the prescribed drugs. Almost a fifth of
the patients were using non-prescribed dyspepsia
medication, mainly antacids. Use of prescribed med-
ication ‘‘on demand’’ appeared to be more prevalent in
patients who had received antacids or prokinetics than
in patients who had received proton pump inhibitors.
The use of non-prescribed drugs was associated with
less severe dyspepsia symptoms, intermittent use of the
prescribed medication, and poorer mental health. In
addition, a higher number of visits to the GP appeared
Table I. Patient characteristics (n/518).
Age/55 years 317 (61%)
Women 284 (56%)
Education level:
Low 252 (51%)
Medium 159 (32%)
High 88 (17%)
First visit /12 months ago 373 (78%)
Last visit /12 months ago 196 (38%)
Number of visits previous 12 months:
0 196 (38%)
1 or 2 222 (43%)
3/6 92 (18%)
Dyspepsia severity:
Low 38 (7%)
Medium 236 (46%)
High 244 (47%)
Prescriptions:
Antacids/prokinetics 72 (14%)
H2ra 85 (16%)
PPI 309 (60%)
Continued use of medication: 273 (61%)
Use of analgesics 70 (14%)
Use of sedatives/hypnotics 83 (16%)
Medication as cause of change 278 (54%)
Self-reported mental health (mean) 21.8
Self-reported vitality (mean) 15.1
Absolute numbers, percentages in parentheses unless otherwise
mentioned.
Table II. Use of prescribed and non-prescribed medication
(n/518).
Prescribed medication:
Used daily 383 (74%)
Used ‘‘on demand’’ 122 (25%)
Never used 6 (1%)
Drug use /one year 383 (74%)
Use of non-prescribed drugs for dyspepsia 101 (19%)
Use of non-prescribed h2RA 21 (4%)
Use of non-prescribed antacids 76 (15%)
Absolute numbers, percentages in parentheses.
Table III. Predictors of prescribed medication use ‘‘on demand’’
and use of non-prescribed drugs (n/518).
Predictor On demand Non-prescribed
drugs
High dyspepsia severity 0.39 {0.20;0.75}*
No of visits in previous 12 months:
1 or 2 2.27 {1.40;3.66}*
3 to 6 2.40 {1.31;4.40}*
Continuous medication
use
0.07 {0.04;0.12}* 0.60 {0.38;0.96}*
Antacid or prokinetic
prescription
1.71 {1.00;2.93}*
PPI prescription 0.39 {0.26;0.58}*
Relatively poor mental
health
1.79 {1.11;2.86}*
Last visit /12 months
ago
0.52 {0.33;0.81}*
Logistic regression analysis OR (95% CI).
*/ significant.
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to be associated with both use on demand and use of
non-prescribed drugs.
Shaw also found an association between the use of
non-prescribed h2RAs and a higher number of visits
to the GP (20). In the past decade, the use of non-
prescribed drugs has become more common, because
many drugs have been introduced onto the over the
counter (OTC) market. In The Netherlands, h2RAs
and antacids can be bought at the supermarket,
although the dose of h2RAs is half that of the lowest
prescription dose. TV commercials and other market-
ing strategies are used to promote this type of self-
medication. GPs’ attitudes towards the use of non-
prescribed drugs for dyspepsia vary from ignorance to
recommendation (16,21). Self-reports by patients on
the effectiveness of chronic non-prescribed histamine-
2 receptor antagonist use showed that they rarely
relieve symptoms (20). Opposing views exist as to
whether it is an advantage that patients with dyspepsia
use non-prescribed drugs (12,13,22).
Our study did not show an association between
symptom severity or absence of symptoms and use on
demand. However, previous research into long-term
PPI use has shown that use on demand was related to
symptom severity and the presence or absence of
symptoms (8). An explanation for these inconsistent
findings can be found in differences between study
populations and the method of measuring the severity
of symptoms.
Discussion continues as to whether or not to
encourage use on demand, especially with regard to
PPIs (7). For a minority of patients with dyspepsia
(patients with GORD) the intermittent or on-demand
use of PPIs has been discussed by the Genval Work-
shop (23), which concluded that for endoscopically
negative patients on-demand therapy in long-term
management could be included. No clear recommen-
dations on this subject are given in previous or recent
Dutch guidelines for general practice because of
insufficient evidence (10,11). The Scottish national
guideline (24) mentions intermittent use as an alter-
native, if necessary, for patients with functional
dyspepsia but explanation of conditions or evidence
is lacking. Greater insight into the value of use on
demand is needed to assess the finding that a
considerable number of dyspepsia patients use their
medication on demand, instead of continuously in
compliance with their prescription.
Selection bias as well as self-report bias may have
been present in this study. The non-responders were
comparable in age and sex with the responders. In a
Dutch study (25) on patients using long-term acid-
suppressive drugs, the mean age and percentage of
women were similar to those in our study. Self-
reported information concerning use on demand was
about the same as that mentioned in a cross-sectional
study on patients in general practice (7). Self-reports
may be unreliable because of errors or other factors;
we tried to reduce these issues as much as possible by
using examples and asking patients to tick boxes.
More frequent evaluation of medical treatment by
GPs may contribute to changing patients’ patterns of
drug use. More visits to GPs have an effect on both
on-demand use and the use of non-prescribed drugs
(this study). Therefore, it should be possible to
increase the appropriate use of drugs for dyspepsia
through communication on this subject. According to
the Dutch guideline for general practice (10) all
patients on long-term prescriptions should be seen at
least once every 6 months. This policy could result in
an increase of on-demand use of prescribed drugs,
which suggests that GPs are not aware of or do not
accept how patients take their prescribed drugs. When
the decision to take medication on demand is shared
by the GP and the patient this could result in better
evaluation of medical therapy.
It has also been suggested that patients experience
other factors, such as lifestyle and habits, as being
responsible for the burden of dyspepsia (6). This
implies that the appropriate use of drugs for these
patients might be of less importance.
Clear information to patients about how to use their
prescribed dyspepsia medication and when to stop
taking it could contribute to decreasing unnecessary
drug use but to date this is lacking in practice (14).
Shared decision-making might influence patients’
adherence to treatment decisions (26). The results of
this study suggest that communication on use accord-
ing to the prescription, use on demand, use of OTC
drugs, and health education should be addressed to all
patient groups. Further studies on these topics could
focus on shared decision-making for patients with
dyspepsia to improve medical care.
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